PRL and Hashimoto thyroiditis: The most likely explanation for a mitigatory impact of Hashimoto thyroiditis on the prolactin-lowering effect of metformin is interaction at the level of the pituitary adenosine 5′-monophosphate-activated protein kinase (AMPK) pathway.